Merck KGaA's Erbitux Gets EU Backing for Wider Use (Update3) - Bloomberg


Wall Street Journal Blogs
Merck KGaA's Erbitux Gets EU Backing for Wider Use (Update3)
Bloomberg -9 hours ago
By Eva von Schaper May 30 (Bloomberg) — Merck KGaA and ImClone Systems Inc.'s Erbitux was backed for approval by a European Union advisory panel as a first-choice therapy for patients whose colon cancer has spread to other parts of the body.
UPDATE 1-EU drugs panel recommends first-line Erbitux useReuters
Merck KGaA says Erbitux receives positive opinion from EU's CHMP …Forbes
Wall Street Journal Blogs - Washington Post - CNNMoney.com - CNBC
all 43 news articles

More: continued here

Share and Enjoy:These icons link to social bookmarking sites where readers can share and discover new web pages.
  • BlinkList
  • blogmarks
  • co.mments
  • del.icio.us
  • De.lirio.us
  • digg
  • Furl
  • Ma.gnolia
  • NewsVine
  • Reddit
  • Shadows
  • Simpy
  • Smarking
  • Spurl
  • YahooMyWeb



   Posted in Health News    

Subscribe RSS 2.0 feed. Leave a response, or Trackback from your own site.





No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment